Luther King Capital Management (LKCM)’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $15.7M | Sell |
232,579
-9,441
| -4% | -$629K | 0.06% | 152 |
|
|
2026
Q1 | $15.2M | Buy |
242,020
+40,966
| +20% | +$2.85M | 0.07% | 146 |
|
|
2025
Q4 | $13.3M | Sell |
201,054
-31,529
| -14% | -$2.04M | 0.05% | 155 |
|
|
2025
Q3 | $15.7M | Sell |
232,583
-27,410
| -11% | -$2.17M | 0.06% | 144 |
|
|
2025
Q2 | $22.7M | Buy |
259,993
+17,343
| +7% | +$1.36M | 0.1% | 128 |
|
|
2025
Q1 | $16.6M | Buy |
242,650
+20,518
| +9% | +$1.67M | 0.08% | 136 |
|
|
2024
Q4 | $17.3M | Buy |
222,132
+8,887
| +4% | +$658K | 0.07% | 136 |
|
|
2024
Q3 | $14.3M | Buy |
213,245
+56,365
| +36% | +$4.63M | 0.06% | 137 |
|
|
2024
Q2 | $17.8M | Buy |
156,880
+11,013
| +8% | +$1.39M | 0.08% | 130 |
|
|
2024
Q1 | $20.2M | Buy |
145,867
+29,714
| +26% | +$3.74M | 0.09% | 124 |
|
|
2023
Q4 | $14.4M | Buy |
116,153
+70,433
| +154% | +$7.2M | 0.07% | 138 |
|
|
2023
Q3 | $4.27M | Buy |
45,720
+58
| +0.1% | +$6.54K | 0.02% | 215 |
|
|
2023
Q2 | $5.87M | Buy |
45,662
+2
| +0% | +$242 | 0.03% | 190 |
|
|
2023
Q1 | $5.3M | Sell |
45,660
-45
| -0.1% | -$5.04K | 0.03% | 188 |
|
|
2022
Q4 | $5.18M | Buy |
45,705
+45
| +0.1% | +$4.94K | 0.03% | 179 |
|
|
2022
Q3 | $3.68M | Sell |
45,660
-40
| -0.1% | -$3.39K | 0.02% | 212 |
|
|
2022
Q2 | $3.41M | Sell |
45,700
-228
| -0.5% | -$20.8K | 0.02% | 227 |
|
|
2022
Q1 | $5.87M | Buy |
45,928
+42,996
| +1,466% | +$4.7M | 0.03% | 182 |
|
|
2021
Q4 | $394K | Buy |
2,932
+12
| +0.4% | +$1.72K | ﹤0.01% | 522 |
|
|
2021
Q3 | $399K | Buy |
+2,920
| New | +$368K | ﹤0.01% | 516 |
|
|
2018
Q1 | – | Sell |
-54,700
| Closed | -$785K | – | 523 |
|
|
2017
Q4 | $785K | Sell |
54,700
-2,880
| -5% | -$37.4K | 0.01% | 384 |
|
|
2017
Q3 | $704K | Sell |
57,580
-160
| -0.3% | -$2.83K | 0.01% | 381 |
|
|
2017
Q2 | $1.06M | Buy |
57,740
+9,320
| +19% | +$172K | 0.01% | 340 |
|
|
2017
Q1 | $1.03M | Buy |
48,420
+360
| +0.7% | +$7.03K | 0.01% | 342 |
|
|
2016
Q4 | $717K | Sell |
48,060
-20,320
| -30% | -$360K | 0.01% | 376 |
|
|
2016
Q3 | $1.5M | Sell |
68,380
-10,900
| -14% | -$243K | 0.01% | 311 |
|
|
2016
Q2 | $1.57M | Sell |
79,280
-107,820
| -58% | -$1.84M | 0.02% | 311 |
|
|
2016
Q1 | $3.18M | Sell |
187,100
-328,300
| -64% | -$5.48M | 0.03% | 262 |
|
|
2015
Q4 | $10.6M | Sell |
515,400
-123,500
| -19% | -$2.57M | 0.1% | 187 |
|
|
2015
Q3 | $13.7M | Sell |
638,900
-103,020
| -14% | -$2.3M | 0.13% | 165 |
|
|
2015
Q2 | $14.8M | Sell |
741,920
-2,209,800
| -75% | -$38.8M | 0.13% | 175 |
|
|
2015
Q1 | $46M | Sell |
2,951,720
-840,276
| -22% | -$12.7M | 0.39% | 72 |
|
|
2014
Q4 | $52.2M | Sell |
3,791,996
-358,724
| -9% | -$4.39M | 0.42% | 67 |
|
|
2014
Q3 | $41.5M | Buy |
4,150,720
+198,760
| +5% | +$2.03M | 0.34% | 80 |
|
|
2014
Q2 | $39.2M | Buy |
3,951,960
+298,720
| +8% | +$2.65M | 0.31% | 93 |
|
|
2014
Q1 | $37.8M | Sell |
3,653,240
-880,800
| -19% | -$9.1M | 0.31% | 99 |
|
|
2013
Q4 | $40.1M | Sell |
4,534,040
-159,920
| -3% | -$1.27M | 0.32% | 102 |
|
|
2013
Q3 | $33.1M | Sell |
4,693,960
-1,120,840
| -19% | -$7.1M | 0.28% | 120 |
|
|
2013
Q2 | $32.6M | Buy |
+5,814,800
| New | +$27.9M | 0.3% | 108 |
|
Other funds holding DXCM
Luther King Capital Management (LKCM)'s DXCM Position: Q2 2026 in Review
Luther King Capital Management (LKCM) reduced its DexCom (DXCM) stake by 3.9% in Q2 2026, selling an estimated $629K and leaving 232,579 shares worth $15.7M. The position accounts for 0.06% of the portfolio, ranked #152.
Luther King Capital Management (LKCM) first reported a position in DXCM in Q2 2013 and has held it in 39 quarters since. The position peaked at $52.2M in Q4 2014. 968 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.
- Luther King Capital Management (LKCM) held 232,579 shares of DexCom worth $15.7M as of Q2 2026.
- Luther King Capital Management (LKCM) sold 9,441 DexCom shares in Q2 2026, an estimated $629K.
- DexCom made up 0.06% of Luther King Capital Management (LKCM)'s portfolio in Q2 2026, its #152 holding.
- Luther King Capital Management (LKCM) first reported a position in DexCom in Q2 2013 and has held it in 39 quarters since.
- Luther King Capital Management (LKCM)'s DexCom position peaked at $52.2M in Q4 2014.
- 968 funds tracked by Wall St. Rank held DexCom as of Q2 2026.
Based on Luther King Capital Management (LKCM)'s 13F filing for Q2 2026, filed 10 Aug 2026.